Case Series
Volume 11 Issue 8 - 2020
Vitelliform Macular Dystrophy; Treat or Observe Literature Review of Treatment
Abdulrahman A Alghadyan* and Abdulaziz A Rushood
Kahhal Medical Complex, Imam Abdulrahman University, King Fahd Hospital of the University, Dammam, Saudi Arabia
*Corresponding Author:Abdulrahman A Alghadyan, Kahhal Medical Complex, Imam Abdulrahman University, King Fahd Hospital of the University, Dammam, Saudi Arabia.
Received: June 11, 2020; Published: July 30, 2020


We are reporting two cases with vitelliform macular dystrophy; one represents Best’s disease with marked changes during the observation for 3 years. The second case represents the adult onset of the vitelliform macular dystrophy who demonstrated improvement after anti-vegf therapy.

Keywords: Vitelliform Macular Dystrophy; Therapy; Best’s Disease


  1. Adams J. “Case showing peculiar changes in the macula”. Transactions of the ophthalmological societies of the United Kingdom 3 (1883): 113-114.
  2. Best F. “Ueber eine hereditaere Maculaaffektion”. Z Augenheilk 13 (1905): 199-212. 
  3. Boon CJ., et al. “The spectrum of ocular phenotypes caused by mutations in the BEST1 gene”. Progress in Retinal and Eye Research 28.3 (2009): 187-205.
  4. Petrukhin K., et al. “Identification of the gene responsible for Best macular dystrophy”. Nature Genetics 19 (1998): 241-247. 
  5. Montero JA., et al. “Intravitreal Bevacizumab for adult onset vitelliform dystrophy; a case report”. European Journal of Ophthalmology 17.6 (2007): 983-986.
  6. Tiosano L., et al. “Bevacizumab treatment for choroidal neovascularization associated with adult onset fovomacular vitelliform dystrophy”. The European Journal of Ophthalmology 24.6 (2014): 890-896. 
  7. Velazquez-Villoria D., et al. “Intravitreal Bevacizumab for choroidal neovascularization associated with Best’s disease”. Archivos de la Sociedad Española de Oftalmología 89.10 (2014): 405-407.
  8. Celea C., et al. “Evaluation of choroidal Neovascular membrane in Best disease after single intravitreal Bevacizumab Case Report”. Maedica 10.1 (2015): 61-64.
  9. Cinnamon G., et al. “Functional and anatomical changes in bilateral neovascularization associated with vitelliform macular dystrophy after intravitreal bevacizumab”. Journal of Ocular Pharmacology and Therapeutics 28.6 (2012): 643-646.
  10. Leu J., et al. “Choroidal neovascularization secondly to best’s disease in a 13 years old boy treated with Bevacizumab”. Graefe's Archive for Clinical and Experimental Ophthalmology 245.11 (2007): 1723-1725.
  11. Chhablani J and Jalali S. “Intravitreal bevacizumab for choroidal neovascularization secondary to Best Vitelliform macular dystophy in a 6 years old child”. The European Journal of Ophthalmology 22.4 (2012): 677-679.
  12. Perol J., et al. “Intravitreal bevacisumab treatment for choroidal neovascularization in Best disease”. Journal Français D'Ophtalmologie 34.5 (2011): 281-286.
  13. Richi E., et al. “Intravitreal bevacizumab for neovascular membrane associated with Best vitelliform dystrophy”. Indian Journal of Ophthalmology 58.2 (2010):160-162.
  14. Lee JY., et al. “Spectral domain optical coherence tomography in a patients with adult onset Vitelliform dystrophy treated with intravitreal bevacizumab”. Ophthalmic Surg Lasers Imaging 40.3 (2009): 319-321.
  15. Iannaccone A., et al. “Autosomal recessive Best Vitelliform macular dystrophy: report of a family and management of early onset neovascular complication”. Archives of Ophthalmology 129.2 (2011): 211-217.
  16. Gallego-Pinazo R., et al. “Primary intravitreal ranibizumab for adult onset foveomacular vitelliform dystrophy”. Archive for Clinical and Experimental Ophthalmology 249.3 (2011): 45508. 
  17. Kandula S., et al. “Adult onset vitelliform detachment to monthly intravitreal ranibizumab”. Ophthalmic Sure Lasers Imaging 41 (2010): S81-S84.
  18. Mimoun G., et al. “Ranibizumab for choroidal Nrovascularization associated with adult onset foveomacular vitelliform dystrophy: one year result”. Retina 33.3 (2013): 513-521.
  19. Preito-Calvo E., et al. “Ranibizumab intravítreo en neovascularización coroidea secundaria a distrofia foveomacular viteliforme del adulto”. Archivos de la Sociedad Española de Oftalmología 87.5 (2012): 149-152.
  20. Querques G., et al. “Intravitreal ranibizumab for type 3 choroidal neovasularization complicating adult onset foveomacular vitelliform dystrophy”. Journal Français D'Ophtalmologie 36.1 (2013): 1-4.
  21. Heidary F., et al. “Itraretinal ranibizumab for choroidal neovascularization in Best vitelliform macular dystrophy”. The Journal of Pediatric Ophthalmology and Strabismus 15.48 (2011): 19-22.
  22. Barbazetto I., et al. “Idiopathic acute exudative polymorphous vitelliform maculopathy clinical spectrum and multimodal imaging characteristics”. Ophthalmology 125.1 (2018): 75-88.
  23. GÜndüz K., et al. “Acute polymorphous paraneoplastic vitelliform maculopathy managed withintravitreal Aflibercept”. Ophthalmic Sure Lasers imaging Retina 48.10 (2017): 844-850.
  24. Braimah Iz., et al. “Intravitreal ziv-flibercept for the treatment of choroidal neovascularization associated with conditions other than age related macular degeneration”. British Journal of Ophthalmology 101.9 (2017): 1201-1205. 
  25. Eugun E., et al. “Photodynamic therapy and vitelliform lesion”. Retina 24.3 (2004): 399-406.
  26. Andrade RE., et al. “Photodynamic therapy with verteporfin for sub foveal choroidal neovascularization in Best’s disease”. American Journal of Ophthalmology 136.6 (2003): 1179-1181.
  27. Murro V., et al. “OCTA images of choroidal neovascularization treated using photodynamic therapy in young patient with Best macular dystrophy”. Ophthalmic Surg Lasers Imaging Retina 49.12 (2018): 969-973.
  28. Richi P., et al. “Photodynamic therapy for childhood neovascular membrane associated with vitelliform dystrophy”. Retinal Cases and Brief Reports 3.3 (2009): 288-292.
  29. Viola F., et al. “Bilateral Juvenile choroidal neovascularization with Best’s vitelliform dystrophy observation versus photodynamic therapy”. The Journal of Pediatric Ophthalmology and Strabismus 47.2 (2010): 121-122.
  30. Sodi A., et al. “Long term result of photodynamic therapy for choroidal neovascularization in pedantic patients with Best Vitelliform macular dystrophy”. Ophthalmic Genetics 36.2 (2015): 168-174.
  31. Frennesson CI., et al. “Best vitelliform macular dystrophy in a Swedish family: genetic analysis an a seven years follow up of photodynamic treatment of a young boy with choroidal neovascularization”. Acta Ophthalmologica 92.3 (2014): 238-242.
  32. Ozdek S., et al. “Photodynamic therapy for Best disease complicated by choroidal Neovascularization in children”. The Journal of Pediatric Ophthalmology and Strabismus 49.4 (2012): 216-221.
  33. Scupola A., et al. “Intravitreal dexamethasone insert for acute exudative Polymorphous vitelliform maculopathy”. The European Journal of Ophthalmology 24.5 (3014): 803-807.
  34. Murtagh P., et al. “Aute exucutive polymorphous vitellioform maculopathy syndrome: Natural history and evolution of fundal and OCT images over time”. BMJ Case Report (2018).
  35. Agarwal A. “Gass’ Atlas of Macular Diseases”. 5th edition. Philadelphia: Saunders (2012).
  36. Guziewicz KE., et al. “BEST1 gene therapy corrects a diffuse retina-wide microdetachment modulated by light exposure”. Proceedings of the National Academy of Sciences (2018).
Citation: Abdulrahman A Alghadyan and Abdulaziz A Rushood. “Vitelliform Macular Dystrophy; Treat or Observe Literature Review of Treatment”. EC Ophthalmology 11.8 (2020): 45-53.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

January Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the January issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before January 17, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to